MONONIT 40

Country: Israel

Language: English

Source: Ministry of Health

Active ingredient:

ISOSORBIDE-5-MONONITRATE

Available from:

PERRIGO ISRAEL PHARMACEUTICALS LTD

ATC code:

C01DA14

Pharmaceutical form:

TABLETS

Composition:

ISOSORBIDE-5-MONONITRATE 40 MG

Administration route:

PER OS

Prescription type:

Required

Manufactured by:

PERRIGO ISRAEL PHARMACEUTICALS LTD

Therapeutic group:

ISOSORBIDE MONONITRATE

Therapeutic area:

ISOSORBIDE MONONITRATE

Therapeutic indications:

Prophilactic treatment of Angina pectoris. Treatment of congestive heart failure.

Authorization date:

2010-11-30

Patient Information leaflet

drugs for the treatment of migraines of the ergot group (in large
dosages), noradrenaline.
Side effects: In addition to the desired effect of the medicine,
adverse
reactions may occur during the course of taking this medicine, for
example: nausea/vomiting, headache (see below), dizziness - especially
when rising from a lying to a standing position (see "Warnings"), fast
heartbeat, flushing of face and neck, weakness. These side effects
usually disappear within a short time following the period of
adaptation
to the medicine. However, if they persist and/or are bothersome,
consult your doctor.
SIDE EFFECTS THAT REQUIRE SPECIAL ATTENTION:
Skin rash or irritation,
dryness of the mouth, persistent headache (see below), blurred vision
(rare): stop the treatment and refer to the doctor.
Side effects resulting from overdosage: Bluish-coloured lips,
fingernails
or palms of the hands, pressure in head.
In the event that you experience side effects not mentioned in this
leaflet, or if there is a change in your general health, consult your
doctor immediately.
Dosage: According to doctor's instructions only.
Do not exceed the recommended dosage.
THIS MEDICINE IS NOT USUALLY INTENDED FOR CHILDREN AND INFANTS.
Directions for use: Do not chew! Swallow the medicine with a large
amount of water after meals. The tablets can be halved but not
crushed.
How can you contribute to the success of the treatment?
Complete the full course of treatment as instructed by the doctor.
Even if there is an improvement in your health, do not discontinue
use of this medicine before consulting your doctor; and even then
this should be done gradually.
During treatment with this medicine, especially at the beginning, you
may suffer from headaches which accompany the action of this
medicine; this may be overcome by taking aspirin or similar pain
reliever. You should try to continue treatment in spite of the pain.
If
the pain persists or worsens, consult your doctor about continuation
of treatment.
Avoid poisoning! This medicine and all other medicines,